| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8225553 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 8 Pages |
Abstract
Our data provide further evidence for FAK as important determinant of radiation survival, which acts in the same signaling axis as Akt1 and ERK1/2. These data strongly support our hypothesis that FAK is a relevant molecular target for HNSCC radiotherapy.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Stephanie PhD, Iris MD, Nils MD, PhD,